Effect of Body Mass Index on Mortality and Morbidity in Patients Undergoing Coronary Artery Bypass Grafting Surgery
AbstractBackground: This study aims to investigate the effect of body mass index (BMI) on mortality and morbidity in patients undergoing coronary artery bypass grafting (CABG) surgery.
Methods: We retrospectively evaluated the medical records of 403 patients undergoing coronary artery bypass surgery in our center. The patients were divided into 5 groups according to their BMI values. Preoperative demographic characteristics, operative data, and postoperative complications during the six-month follow-up period were compared between the groups.
Results: There were no statistically significant differences between the groups except the coexistence of peripheral artery disease (P = .009), ejection fraction (P = .021) and chronic obstructive pulmonary disease (P = .044). There were no statistically significant differences between the groups in terms of postoperative complications. No relationship was found between postoperative complications and the implemented surgical procedures. An overall 30-day mortality rate of 1.48% was observed, and the six-month mortality rate was 1.7%.
Conclusion: According to this study, obesity does not lead to an increased risk of mortality and other adverse outcomes after CABG surgery. However, obesity may prolong hospital stay and increase the cost of CABG operation.
Anderson RP. 1994. First publications from the Society of Thoracic Surgeons National Database. Ann Thoracic Surg 57:6-7.
Atalan N, FazlioÄŸullarÄ± O, Kunt AT, et al. 2012. Effect of body mass index on early morbidity and mortality after isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 26:813-17.
Berchtold P, Jorgens V, Finke C, Berger M. 1981. Epidemiology of obesity and hypertension. Int J Obes 5:1-7.
Birkmeyer NJ, Charlesworth DC, Hernandez F, et al. 1998. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Circulation 97:1689-94.
De Backer G, Ambrosioni E, Borch-Johnsen K, et al. 2003. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10:10.
Fontaine KR, Redden DT, Wang C, et al. 2003. Years of life lost due to obesity. JAMA 289:187.
Fried LP, Tangen CM, Walston J, et al. 2008. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:146-56.
Garrow JS, Webster J. 1985. Quetelet’s index as a measure of fatness. Int J Obes 9:147.
Gruberg L, Mercado N, Milo S, et al. 2005. Impact of BMI on the outcome of patients with multi vessel disease randomized to either CABG or stenting in the ARTS trial: the obesity paradox? Am J Cardiol 95:439-44.
Hubert HB, Feinleib M, Mc Namara PM, Castelli WP. 1983. Obesity as an independent risk factor for cardiovascular disease: a 26 year follow up of participants in the Framingham Heart study. Circulation 67:968-77.
Lavie CJ, Ventura HO, Messerli FH. 1992. Left ventricular hypertrophy. Its relationship to obesity and hypertension. Postgrad Med 91:131-43.
Lavie CJ, Milani RV, Ventura HO. 2009. Obesity and cardiovascular disease risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925-32.
Moulton M, Creswell L, Mackey ME, Cox JL, Rosenbloom M. 1996. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 94:87-92.
Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S. 2003. Adverse events in coronary artery bypass graft trials: asystematic review and analysis. Heart 89:767-72.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13.
Oliveira B, Soares EF, Santos CA, et al. 2011. Risk factors for mediastinitis after coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc 26:27-35.
Oreopoulos A, Mc Alister FA, Zadeh KK, et al. 2009. The relationship between body mass index, treatment and mortality in patients with established coronary artery disease. Eur Heart J 30:2584-92.
Orgeas MG, Troch G, Azoulay E, et al. 2004. Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med 30:437-43.
Orhan G, BiÃ§er Y, Aka SA, et al. 2004. Coronary artery bypass graft operations can be performed safely in obese patients. Eur J Cardiothorac Surg 25:212-7.
Perrotta S, Nilsson F, Brandrup-Wognsen G, et al. 2007. Body mass index and outcome after coronary artery bypass surgery. J Cardiovasc Surg 48:239.
Potapov EV, Loebe M, Anker S, et al. 2003. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 24:1933-41.
Shirzad M, Karimi A, Armadi SH, et al. 2009. Effects of body mass index on early outcome of coronary artery bypass surgery. Minerva Chir 64:17-23.
Stamou SC, Nussbaum M, Stiegel RM, et al. 2011. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox? Ann Thorac Surg 91:42.
TÃ¼ik. 2008. Death Statistics. ISBN 978-975-19-4660-7, 25.
World Health Organization. 2008. Global strategy on diet, physical activity, and health. Available at: http://whqlibdoc.who.int/publications/2009/9789241597418.html. Accessed October 10, 2012.
Youn YN, Kwak YL, Yoo KJ. 2007. Can the EuroSCORE predict the early and mid-term mortality after off-pump coronary artery bypass grafting? Ann Thorac Surg 83:2111–7.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).